According to SCYNEXIS's latest financial reports and stock price the company's current number of shares outstanding is 48,245,559. At the end of 2024 the company had 48,245,559 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2024 | 48.24 M | 0.74% |
2023 | 47.89 M | 0.82% |
2022 | 47.5 M | 78.47% |
2021 | 26.61 M | 150.45% |
2020 | 10.62 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Galmed Pharmaceuticals
GLMD | 6,246,188 | -87.05% | ๐ฎ๐ฑ Israel |
Catalyst Pharmaceuticals CPRX | 116,806,117 | 142.11% | ๐บ๐ธ USA |
Catalent CTLT | 182,000,000 | 277.24% | ๐บ๐ธ USA |
KemPharm KMPH | 34,494,702 | -28.50% | ๐บ๐ธ USA |